Mortality and cause of death after hospital discharge in 10,981 patients with ischemic stroke and transient ischemic attack.
about
Ischemia, Immunosuppression and Infection--Tackling the Predicaments of Post-Stroke ComplicationsEpidemiology and registry studies of stroke in JapanDerivation and validation of in-hospital mortality prediction models in ischaemic stroke patients using administrative data.Administrative data linkage to evaluate a quality improvement program in acute stroke care, Georgia, 2006-2009.Smoking and mortality in stroke survivors: can we eliminate the paradox?A Comparison of the Effects of the GLP-1 Analogue Liraglutide and Insulin Glargine on Endothelial Function and Metabolic Parameters: A Randomized, Controlled Trial Sapporo Athero-Incretin Study 2 (SAIS2).Effectiveness of Hospital Functions for Acute Ischemic Stroke Treatment on In-Hospital Mortality: Results From a Nationwide Survey in Japan.A Randomized Controlled Trial Comparing the Effects of Sitagliptin and Glimepiride on Endothelial Function and Metabolic Parameters: Sapporo Athero-Incretin Study 1 (SAIS1).Disorders of the Autonomic Nervous System after Hemispheric Cerebrovascular Disorders: An Update.Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial.Racial differences in hospital discharge disposition among stroke patients in Maryland.Secondary prophylactic treatment and long-term prognosis after TIA and different subtypes of stroke. A 25-year follow-up hospital-based observational study.Evidence-based risk factors for adverse health outcomes in older patients after discharge home and assessment tools: a systematic review.Sex differences in the injured brain.Men Experience Higher Risk of Pneumonia and Death After Intracerebral Hemorrhage.Hippocampal volume in patients with asthma: Results from the Dallas Heart Study.PPARG gene C161T CT/TT associated with lower blood lipid levels and ischemic stroke from large-artery atherosclerosis in a Han population in Guangdong.Incidence and survival of lacunar infarction in a southern Chinese population: A 7-year prospective study.Cost-Effectiveness of Proton Pump Inhibitor Co-Therapy in Patients Taking Aspirin for Secondary Prevention of Ischemic Stroke.Infectious disease is the most common cause of death among stroke patients: two-years of follow-up.Monocyte-lymphocyte cross-communication via soluble CD163 directly links innate immune system activation and adaptive immune system suppression following ischemic stroke.Predictors of newly diagnosed atrial fibrillation in cryptogenic stroke: a cohort study.Post-stroke pneumonia prevention by angiotensin-converting enzyme inhibitors: results of a meta-analysis of five studies in Asians.Early recurrence of ischemic stroke in Japanese patients: the Japan standard stroke registry study.The Japanese aggrenox (extended-release dipyridamole plus aspirin) stroke prevention versus aspirin programme (JASAP) study: a randomized, double-blind, controlled trial.Causes of Death in Different Subtypes of Ischemic and Hemorrhagic Stroke.Functional innervation of hepatic iNKT cells is immunosuppressive following stroke.Acute pancreatitis is a very rare comorbidity of acute ischemic stroke.Subtypes and One-Year Survival of First-Ever Stroke in Chinese Patients: The Nanjing Stroke Registry
P2860
Q26770298-1CD50E98-57AB-4345-ADDC-8D4941F15D12Q30356649-F8752A7F-3E75-480C-A1C0-B66C4F8F3A51Q30592193-0D0AF425-E589-4860-B968-C97FB86ECBC3Q30884511-FC5A7841-448F-40F5-ACA3-C9F17FE4E26CQ33758422-839C819F-D7F9-41BC-AB82-893B562850F2Q35748827-7292662D-67A5-4B22-8C5B-8F3080C4E18AQ35897536-64A76641-9BD0-4EB4-9549-0868141A6D03Q36155251-4E8AC6D9-5B18-4952-9243-9EC0370B1189Q36253091-2A733F6A-62DA-4155-B26D-115AC3CD2725Q36765350-115C26E9-E1AA-4A1E-AC08-DADFB4D04FA5Q36821783-55768096-EA86-4A09-A2A5-2A918823F2F5Q37599670-BCB6D90D-B265-447F-8DDC-CBBF6C709B3AQ37950507-B04891E4-51DE-45FD-B38D-BAD5140FEB62Q38471576-94C47E33-303C-46AA-B785-AB09DAC8EF9CQ39449784-DD9A19D0-D8ED-40CD-9B5F-ABEC6F06D37EQ39760555-98BE117C-FD7A-4C2D-B598-1EF336EE8019Q40717921-D6C1D49B-43DC-4D16-9C8E-E1431ADD6149Q41129765-2053B5B4-23F5-459F-A308-7A73432ACA28Q41725713-6D10FEDA-350F-4CC1-8B58-2F5FB0FC6B4AQ42256271-BFB3ABAB-E8AB-4890-8250-E355C47B5C0DQ42374943-37E621C5-F8BA-4369-92A2-3873015FF3B9Q43450811-24A9F187-EF05-4FF4-A470-AF62206D3E33Q44922826-CC1AE8D8-B3A4-418C-A66D-089F7C287E27Q45147508-1262BA18-FCF9-49E6-B742-A7C9296FB772Q45861292-6B3289E8-4B31-4B4B-9AF6-BD54B6F8CD8AQ47654123-641213C2-C8AA-44D2-968E-874C34B18CD9Q48896296-03B12410-BD2E-40B1-A53B-2C70A1E90105Q55397150-AF9DF549-D55B-4E13-B6EC-BA86EE0AF95CQ57253824-8C7EF1EB-984A-4587-B2BC-4723330ECCE3
P2860
Mortality and cause of death after hospital discharge in 10,981 patients with ischemic stroke and transient ischemic attack.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Mortality and cause of death a ...... and transient ischemic attack.
@ast
Mortality and cause of death a ...... and transient ischemic attack.
@en
type
label
Mortality and cause of death a ...... and transient ischemic attack.
@ast
Mortality and cause of death a ...... and transient ischemic attack.
@en
prefLabel
Mortality and cause of death a ...... and transient ischemic attack.
@ast
Mortality and cause of death a ...... and transient ischemic attack.
@en
P2093
P2860
P356
P1476
Mortality and cause of death a ...... and transient ischemic attack.
@en
P2093
Japan Multicenter Stroke Investigators' Collaboration (J-MUSIC)
Kazumi Kimura
Kazuo Minematsu
Seiji Kazui
Takenori Yamaguchi
P2860
P304
P356
10.1159/000083252
P577
2005-01-11T00:00:00Z